ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG
Dry powder formulations for inhalation and their use in the treatment diseases and conditions. The formulation contains a uniform blend of a first spray-dried powder and a second spray-dried powder. The first spray-dried powder contains spray-dried particles of a therapeutically active ingredient di...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Dry powder formulations for inhalation and their use in the treatment diseases and conditions. The formulation contains a uniform blend of a first spray-dried powder and a second spray-dried powder. The first spray-dried powder contains spray-dried particles of a therapeutically active ingredient dispersed in a pharmaceutically acceptably hydrophobic excipient. The second spray-dried powder contains spray-dried particles formed from a pharmaceutically acceptable hydrophobic excipient but are substantially free of any therapeutically active ingredient. The active ingredient in the first spray-dried powder is loaded sufficiently high to compensate for the second spray-dried powder being substantially free of any active ingredient. A process for preparing such formulations is also described. |
---|---|
Bibliography: | Application Number: TW20209101263 |